Jonathan Kimmelman
James ÎÛÎÛ²ÝÝ®ÊÓƵ Professor;
Associate Member of the Dept of Experimental Medicine
PhD in Molecular Biophysics and Biochemistry from Yale University
Jonathan Kimmelman, PhD, is James ÎÛÎÛ²ÝÝ®ÊÓƵ Professor of Biomedical Ethics at ÎÛÎÛ²ÝÝ®ÊÓƵ University. His research group, STREAM (Studies in Translation, Ethics and Medicine) uses empirical and theoretical methods to understand the ethical, policy, and scientific dynamics of developing new drugs. Kimmelman received the Maud Menten New Investigator Prize (2006), a CIHR New Investigator Award (2008), a Humboldt Bessel Award (2014), and was elected a Hastings Center Fellow (2018). He has sat on various advisory bodies within the U.S. NHLBI and NIAID, served for four tours of duty on U.S. National Academies of Medicine committees, and chaired the International Society of Stem Cell Research Guidelines for Stem Cell Research and Clinical Translation revision task force 2015-16. His research has been covered in major media outlets, including NPR’s All Things Considered, STATNews, and Nature. Kimmelman is deputy editor at Clinical Trials, and associate editor at Med.
 PHIL 543B: Medical Ethics: The Ethics of Human Experimentation
Jonathan Kimmelman's research centers on the ethical, social, and policy challenges in testing novel medical technologies in human beings ("translational clinical research"). Current projects are investigating risk, prediction, validity and knowledge value across the trajectory of drug development. Kimmelman directs the .
Other research areas are drug development, animal research, reproducibility, meta-research, and clinical trials.